Messages
12/30/2023
11 : 44
Our best research of 2023
Recapping 17 of our analyst picks from the past year, including our global VC ecosystem rankings and whether or not ESG investors are underperforming. Read online | Don't want to receive these
12/29/2023
11 : 44
Generative AI's fiery year, a timeline
See how VC moved across Europe in 2023; sustainable investing opportunities in indoor farming; mobility tech powers back Read online | Don't want to receive these emails? Manage your subscription.
12/28/2023
11 : 14
5 top sports deals of 2023
Investors hold out on healthcare IT; funding fades for digital health; Europe's top 10 venture deals of 2023 Read online | Don't want to receive these emails? Manage your subscription. Log in
12/27/2023
11 : 14
Here's the VCs of insurtech's rally
Has plant-based meat peaked?; Japan's private markets set for takeoff; take-privates on display in top buyouts Read online | Don't want to receive these emails? Manage your subscription. Log in
12/26/2023
11 : 34
A 2024 IPO, but at what cost?
Meet the AI unicorns of 2023; VC's primer on biopharma; what's the outlook for distressed debt? Read online | Don't want to receive these emails? Manage your subscription. Log in The Daily
12/24/2023
11 : 44
Will an AI be your next VC?
Plus: One industry that will outperform in '24, unicorns approach their peak, European private market predictions & more Read online | Don't want to receive these emails? Manage your
12/23/2023
11 : 14
What we expect in 2024
Our 8 analyst outlooks across US venture capital, private equity, healthcare, emerging technologies, European private capital, and the LP perspective. Read online | Don't want to receive these
12/22/2023
12 : 44
Visions for enterprise, consumer tech in 2024
Biopharma VCs zero in on gene therapy; PE exit troubles hit the mid-market; Vestwell inks $125M Series D Read online | Don't want to receive these emails? Manage your subscription. Log in The Daily
12/21/2023
12 : 34
Many VCs have stopped writing checks
Trends to watch in Europe for 2024; sustainable investing opportunites in indoor farming; Sudo Biosciences takes home $116M Series B Read online | Don't want to receive these emails? Manage your
12/20/2023
12 : 44
Emerging industrial tech's outlook for 2024
How startup verticals fared in 2023; the surge for software is just beginning; PE predictions focus on funds for 2024 Read online | Don't want to receive these emails? Manage your subscription. Log
12/19/2023
12 : 54
Analysts make VC 2024 predictions
GenAI ready to disrupt healthcare in 2024; will Adobe-Figma failure cool M&A in VC?; Tamara nabs unicorn status with $340M Series C Read online | Don't want to receive these emails? Manage your
12/18/2023
13 : 14
A new year for allocators
It's prime time for software; Accel secures $650M for outsize fund; the Amazon trickle-down effect; the most active investors in supply chain tech Read online | Don't want to receive these
12/17/2023
5 : 14
A wave of PE firm IPOs in 2024?
Plus: Plugging into the latest tech, keeping score on impact investing, doing the math on NAV loans & more Read online | Don't want to receive these emails? Manage your subscription. Log in The
12/16/2023
11 : 34
Impact investing + performance data
Also: Our outlook on the evolving LP playbook; Prime time for PE and software; Reflecting on COP28 and the path ahead; E-commerce's long road back... Read online | Don't want to receive these
12/15/2023
13 : 55
Navigating NAV loans
Alternative lending buoys retail fintech; investors eye Japan for Asia-Pacific exposure; fundraising stalls for real assets Read online | Don't want to receive these emails? Manage your
12/15/2023
13 : 44
Investors hold out on healthcare IT
Funding fades for digital health; new year, new VC?; fundraising timelines get longer and longer Read online | Don't want to receive these emails? Manage your subscription. Log in The Daily Pitch:
12/15/2023
13 : 26
Mobility tech bounces back
What really changed after SVB?; retail fintech holds its own; PE slump arrives in the middle market Read online | Don't want to receive these emails? Manage your subscription. Log in The Daily
12/12/2023
17 : 14
What to do with CO2
A16z rounds out its AI strategy; SumUp defies a fintech slowdown; Europe's female founders finish 2023 out strong Read online | Don't want to receive these emails? Manage your subscription. Log
12/11/2023
12 : 24
Drilling down on impact investing performance
Generative AI's barbell strategy; VC gives insurtech startups a boost; meet the AI unicorns of 2023 Read online | Don't want to receive these emails? Manage your subscription. Log in The Daily
12/10/2023
11 : 14
Why hedge funds are leaving VC
Plus: Biopharma VCs back to stable bets, fundraising slows overall, cash flows into generative AI & more Read online | Don't want to receive these emails? Manage your subscription. Log in The